Circadian clock protein BMAL1 regulates melanogenesis through MITF in melanoma cells

Abstract

Solar ultraviolet B radiation (UVB) is one of the leading causes of various skin conditions, including photoaging, sunburn erythema, and melanoma. As a protective response, the skin has inbuilt defense mechanisms, including DNA repair, cell cycle, apoptosis, and melanin synthesis. Though DNA repair, cell cycle, and apoptosis are clock controlled, the circadian mechanisms associated with melanin synthesis are not well understood. Using human melanocytes and melanoma cells under synchronized clock conditions, we observed that the microphthalmia‐associated transcription factor (MITF), a rate‐limiting protein in melanin synthesis, is expressed rhythmically with 24‐hr periodicity in the presence of circadian clock protein, BMAL1. Furthermore, we demonstrated that BMAL1 binds to the promoter region of MITF and transcriptionally regulates its expression, which positively influences melanin synthesis. Finally, we report that an increase in melanin levels due to BMAL1 overexpression protects human melanoma cells from UVB. In conclusion, our studies provide novel insights into the mechanistic role of the circadian clock in melanin synthesis and protection against UVB‐mediated DNA damage and genomic instability.

Document Details

Document Type
Pub Defense Publication
Publication Date
Jul 06, 2021
Source ID
10.1111/pcmr.12998

Entities

People

  • Bala S C Koritala
  • Kazumasa Wakamatsu
  • Kenneth I Porter
  • Michael G Kemp
  • Panshak Dakup
  • Rajendra P Gajula
  • Ryan Hylton
  • Shobhan Gaddameedhi
  • Soumyadeep Sarkar

Organizations

  • Fujita Health University
  • National Institute of Environmental Health Sciences
  • United States Department of Defense
  • Washington State University
  • Wright State University

Tags

Fields of Study

  • Biology

Readers

  • Circadian Sleep-Wake Regulation and Chronobiology
  • Molecular Biology and Genetics
  • Molecular and Cellular Biology

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech